These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 27721253)
61. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943 [TBL] [Abstract][Full Text] [Related]
62. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma. Shiraha H; Nishina S; Yamamoto K J Cell Biochem; 2011 Mar; 112(3):745-9. PubMed ID: 21328447 [TBL] [Abstract][Full Text] [Related]
63. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction. Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712 [TBL] [Abstract][Full Text] [Related]
64. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells. Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453 [TBL] [Abstract][Full Text] [Related]
65. RUNX3 promoter methylation correlation with pathogenesis of hepatocellular carcinoma in Asians. Lu W; Liu Y; Liu LL; Zhuang PH Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420934 [TBL] [Abstract][Full Text] [Related]
66. [Significance of DNA methylation status of runx3 gene promoter region in acute leukemia]. Lin DJ; Fan RF; Liu XF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):263-6. PubMed ID: 18426645 [TBL] [Abstract][Full Text] [Related]
67. [Methylation of Runx3 promoter in different breast lesions]. Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792 [TBL] [Abstract][Full Text] [Related]
68. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis. Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683 [TBL] [Abstract][Full Text] [Related]
69. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone. Han YX; Liang DY Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387 [TBL] [Abstract][Full Text] [Related]
70. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577 [TBL] [Abstract][Full Text] [Related]
71. Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis. Liang Y; He L; Yuan H; Jin Y; Yao Y J Thorac Dis; 2014 Jun; 6(6):694-705. PubMed ID: 24976992 [TBL] [Abstract][Full Text] [Related]
72. Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP-1. Chen Y; Wei X; Guo C; Jin H; Han Z; Han Y; Qiao T; Wu K; Fan D Int J Cancer; 2011 Oct; 129(7):1586-98. PubMed ID: 21128246 [TBL] [Abstract][Full Text] [Related]
73. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Nakase Y; Sakakura C; Miyagawa K; Kin S; Fukuda K; Yanagisawa A; Koide K; Morofuji N; Hosokawa Y; Shimomura K; Katsura K; Hagiwara A; Yamagishi H; Ito K; Ito Y Br J Cancer; 2005 Feb; 92(3):562-9. PubMed ID: 15685235 [TBL] [Abstract][Full Text] [Related]
74. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis. Gu X; Xue JQ; Zhu X; Ye MS; Zhang WH Tumour Biol; 2014 Sep; 35(9):9395-404. PubMed ID: 24952891 [TBL] [Abstract][Full Text] [Related]
75. Clinicopathological significance and potential drug target of RUNX3 in breast cancer. Yu YY; Chen C; Kong FF; Zhang W Drug Des Devel Ther; 2014; 8():2423-30. PubMed ID: 25525332 [TBL] [Abstract][Full Text] [Related]
76. Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer. Nomoto S; Kinoshita T; Mori T; Kato K; Sugimoto H; Kanazumi N; Takeda S; Nakao A Br J Cancer; 2008 May; 98(10):1690-5. PubMed ID: 18475302 [TBL] [Abstract][Full Text] [Related]
77. The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients. Peng D; Zhang H; Sun G J Cancer Res Ther; 2014 Dec; 10 Suppl():292-5. PubMed ID: 25693938 [TBL] [Abstract][Full Text] [Related]
78. Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma. Li Y; Ji X; Su Z; Tong J; Xia S; Chen X; Lu P; Barnie PA; Wang S; Huang X; Xu H Tumour Biol; 2014 Dec; 35(12):12235-44. PubMed ID: 25270738 [TBL] [Abstract][Full Text] [Related]
79. Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population. Rusiecki JA; Al-Nabhani M; Tarantini L; Chen L; Baccarelli A; Al-Moundhri MS Epigenomics; 2011 Aug; 3(4):417-29. PubMed ID: 22126203 [TBL] [Abstract][Full Text] [Related]
80. Association of APC gene promoter methylation and the risk of gastric cancer: A meta-analysis and bioinformatics study. Zhou X; Jiao D; Dou M; Zhang W; Hua H; Chen J; Li Z; Li L; Han X Medicine (Baltimore); 2020 Apr; 99(16):e19828. PubMed ID: 32312003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]